Porton Pharma Solutions Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Nianfeng Ju
Chief executive officer
CN¥1.9m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 10.8% |
| Management average tenure | 2.7yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
Revenues Not Telling The Story For Porton Pharma Solutions Ltd. (SZSE:300363) After Shares Rise 31%
Nov 14
Porton Pharma Solutions Ltd.'s (SZSE:300363) 39% Price Boost Is Out Of Tune With Revenues
Sep 30Porton Pharma Solutions (SZSE:300363) Has Debt But No Earnings; Should You Worry?
Sep 25Is Porton Pharma Solutions (SZSE:300363) Weighed On By Its Debt Load?
Jun 26Analysts Just Shaved Their Porton Pharma Solutions Ltd. (SZSE:300363) Forecasts Dramatically
May 02Does Porton Pharma Solutions (SZSE:300363) Have A Healthy Balance Sheet?
Mar 26Porton Pharma Solutions Ltd.'s (SZSE:300363) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Mar 04CEO
Nianfeng Ju (52 yo)
no data
Tenure
CN¥1,931,300
Compensation
Mr. Nianfeng Ju serves as General Manager of Porton Imp & Exp Ltd. Nianfeng Ju served as the General Manager of Porton Co., Ltd. He serves as a General Manager of Porton Pharma Solutions Ltd.Mr. Ju serves...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥1.93m | 10.8% CN¥ 970.5m | |
| Deputy GM & CFO | 2.7yrs | CN¥1.59m | 0.0055% CN¥ 494.4k | |
| Senior Deputy GM & COO | 2.7yrs | CN¥1.65m | 0.029% CN¥ 2.6m | |
| Deputy General Manager & Secretary | 2.7yrs | CN¥714.90k | 0.016% CN¥ 1.5m | |
| Deputy General Manager | 2.7yrs | CN¥1.39m | 0.026% CN¥ 2.3m | |
| Deputy General Manager | 2.7yrs | CN¥2.09m | 0.020% CN¥ 1.8m | |
| Deputy General Manager | 1.3yrs | no data | no data | |
| Deputy General Manager | 1.3yrs | no data | no data | |
| Deputy General Manager | 1.3yrs | no data | no data |
2.7yrs
Average Tenure
47yo
Average Age
Experienced Management: 300363's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥1.93m | 10.8% CN¥ 970.5m | |
| Non Independent Director | 3.3yrs | CN¥180.00k | no data | |
| Independent Director | 4.3yrs | CN¥180.00k | no data | |
| Employee Representative Supervisor | no data | CN¥212.80k | no data | |
| Independent Director | 2.7yrs | CN¥180.00k | no data | |
| Independent Director | 2.7yrs | CN¥180.00k | no data | |
| Non-Employee Supervisory Board Chairman | no data | no data | no data | |
| Non-Independent Director | 4.3yrs | CN¥180.00k | 0.0027% CN¥ 241.8k | |
| Director | 1.8yrs | no data | no data | |
| Non-Independent Director | 2.7yrs | CN¥180.00k | no data | |
| Non-Independent Director | 2.7yrs | CN¥180.00k | no data | |
| Non-Employee Supervisor | 2.7yrs | no data | no data |
2.7yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 300363's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 22:03 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Porton Pharma Solutions Ltd. is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| Feifei Xu | China Merchants Securities Co. Ltd. |
| Zhu Chen | Citic Securities Co., Ltd. |